Rakas Anja, Persoons Leentje, Daelemans Dirk, Grgić Dajana Kučić, Kraljević Tatjana Gazivoda
Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Marulićev Trg 20, 10000 Zagreb, Croatia.
Molecular Genetics and Therapeutics in Virology and Oncology Research Group, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium.
Molecules. 2025 Apr 15;30(8):1767. doi: 10.3390/molecules30081767.
This study describes the synthesis of -alkylated benzaldehydes -, Schiff bases -, and benzoxazole derivatives - using microwave, ultrasound, and mechanochemical reactions, as well as reactions in deep eutectic solvents in excellent yields, and their antiproliferative and antibacterial activities. The in vitro evaluation of antiproliferative activity for the newly synthesised benzoxazole derivatives - against a diverse panel of human cancer cell lines, such as LN-229, Capan-1, HCT-116, NCI-H460, DND-41, HL-60, K-562, and Z-138 demonstrated that the majority of these benzoxazole derivatives displayed promising anticancer activity, particularly against non-small cell lung cancer (NSCLC) cells (NCI-H460). Notably, several derivatives showed enhanced activity compared to the included reference drug, etoposide. Considering the influence of substituents at position 5 of the benzoxazole ring and positions 3 and 4 of the phenyl ring on the antiproliferative activity, it is evident that derivatives - bearing a methoxy group at position 3 generally exhibit higher activity compared to compounds -, which lack substitution at position 3. Furthermore, derivatives substituted at position 4 with a morpholine substituent, as well as those with an ,-diethyl group, exhibited higher activity compared to other evaluated benzoxazole derivatives. The in vitro antibacterial evaluation against Gram-positive and Gram-negative bacteria revealed that benzoxazole derivative exhibited notable activity, against the Gram-negative bacterium (MIC = 0.25 μg/mL) and the Gram-positive bacterium (MIC = 0.5 μg/mL). The results point out that this class of benzoxazoles can be efficiently synthesized using eco-friendly methods and represent promising candidates for further design and optimization aimed at developing potent antiproliferative agents.
本研究描述了使用微波、超声和机械化学反应以及在深共熔溶剂中的反应,以优异产率合成α-烷基化苯甲醛、席夫碱和苯并恶唑衍生物,以及它们的抗增殖和抗菌活性。对新合成的苯并恶唑衍生物针对多种人类癌细胞系(如LN-229、Capan-1、HCT-116、NCI-H460、DND-41、HL-60、K-562和Z-138)的抗增殖活性进行的体外评估表明,这些苯并恶唑衍生物中的大多数显示出有前景的抗癌活性,特别是对非小细胞肺癌(NSCLC)细胞(NCI-H460)。值得注意的是,与所包含的参考药物依托泊苷相比,几种衍生物显示出增强的活性。考虑到苯并恶唑环5位以及苯环3位和4位上的取代基对其抗增殖活性的影响,显然在3位带有甲氧基的衍生物通常比在3位无取代的化合物表现出更高的活性。此外,在4位被吗啉取代基取代的衍生物以及带有α,β-二乙基的衍生物,与其他评估的苯并恶唑衍生物相比表现出更高的活性。对革兰氏阳性和革兰氏阴性细菌的体外抗菌评估表明,苯并恶唑衍生物对革兰氏阴性菌大肠杆菌(MIC = 0.25 μg/mL)和革兰氏阳性菌金黄色葡萄球菌(MIC = 0.5 μg/mL)表现出显著活性。结果指出,这类苯并恶唑可以使用环保方法有效合成,并且是进一步设计和优化以开发强效抗增殖剂的有前景的候选物。